BlackRock, Inc.
BlackRock, Inc. (BLK) — Form SCHEDULE 13G/A: Ownership over 5% (passive) (amendment)
AI-generated summary
BlackRock, Inc. filed an amended Schedule 13G reporting beneficial ownership of 19,373,309 shares of BIOMARIN PHARMACEUTICAL INC as of 10/31/2026. This represents a passive stake in the company. Managing Director Spencer Fleming signed the filing.
Key facts
- Document
- —
More BLK filings
- 10-Q
Filed Nov 4, 2026
- IRANNOTICE
Filed Nov 4, 2026
- SC 13G/A
Filed Nov 4, 2026
- SC 13G
Filed Nov 4, 2026
- SC 13G/A
Filed Nov 4, 2026
- SC 13G
Filed Nov 4, 2026
Not investment advice. Summaries can contain errors; the SEC filing is the official record.